These medications offer better results than current drugs like semaglutide and tirzepatide
Summary Keywords kidney transplantation, non-HLA antigens, autoantibodies, alloantibodies, antibody mediated rejection, allograft loss Citation Comoli P, Cioni M, Ray B, Tagliamacco A, Innocente A, Caridi G, Bruschi M, Hariharan J, Fontana I, Trivelli A, Magnasco A, Nocco A, Klersy C, Muscianisi S, Ghiggeri GM, Cardillo M, Verrina E, Nocera A and Ginevri F (2022) Anti-glutathione S-transferase theta 1 antibodies correlate with graft loss in non-sensitized pediatric kidney recipients
National Poison Hotline at 1-800-222-1222
Published research has characterized BPC-157 as a cytoprotective agent with activity spanning gastrointestinal, musculoskeletal, and connective tissue models in preclinical studies (1)